<DOC>
	<DOCNO>NCT02040493</DOCNO>
	<brief_summary>This physician sponsor multi-center , non-randomized , prospectively enrol data collection study patient early stage breast cancer treat electronic brachytherapy time surgical resection cancer operate room . The radiation therapy treatment administer electronic brachytherapy use FDA clear Xoft Axxent System .</brief_summary>
	<brief_title>Intra-Operative Radiation Therapy Immediately Following Resection Early Stage Breast Cancer</brief_title>
	<detailed_description>Breast Conserving Therapy ( BCT ) standard treatment option patient stage I II breast cancer . Breast conserve therapy consist surgical removal tumor negative margin , axillary lymph node dissection sentinel node biopsy radiation therapy . Several study show BCT comparable mastectomy term overall disease free survival patient . The major advantage BCT mastectomy breast preservation reduce psychological trauma patient . The major disadvantage BCT prolong time treatment . The whole breast radiation portion BCT add 7 week treatment time . This additional treatment time detriment woman logistically may able meet demand daily irradiation 6-7 week . A new form treatment , breast brachytherapy , develop decrease treatment time require breast irradiation . This treatment use Xoft Axxent system administer intra-operative breast brachytherapy one treatment , time lumpectomy operating room . This study design assess local recurrence , serious adverse event , adverse event severity , cosmesis follow intra-operative radiation therapy ( IORT ) use Xoft Axxent System balloon applicator . The study device FDA clear . The purpose clinical study compile data treatment patient use Xoft Axxent System delivery radiation therapy intra-operative set part breast conserve therapy woman resect , early stage breast cancer .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>General Inclusion Criteria 1 . Age &gt; 45 year 2 . Tumor Tis , T1 , T2 ( â‰¤ 3cm ) , N0 , M0 ( AJC Classification ) 3 . Invasive ductal carcinoma / DCIS Intraoperative Inclusion Criteria 1 . Negative sentinel node assessment 2 . Balloon surface skin distance least 1cm adequate conformance via Intraoperative ultrasound Post procedure Inclusion Criteria 1 . Negative microscopic surgical margins** **If positive margin patient undergo reexcision and/or additional radiation treat physician 's discretion patient exclude protocol data analysis . General Exclusion Criteria 1 . Scleroderma , systemic sclerosis active lupus 2 . Participation investigational drug device study 3 . Previous ipsilateral radiation thorax breast Intraoperative Exclusion Criteria 1 . Intraoperative positive sentinel lymph node biopsy 2 . Inadequate conformance ( great 10 % PTV encompass fluid air physician assessment intraOp ultrasound image ) 3 . Skin space le 1cm via intraOp ultrasound . 4 . A cavity size appropriate 40 70 cc balloon . 5 . Patient becomes unstable physician determines patient good candidate time lumpectomy .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>IORT</keyword>
	<keyword>brachytherapy</keyword>
</DOC>